Is Boundless Bio, Inc. (BOLD) a Buy, Sell, or Hold?
NASDAQ : BOLD
Boundless Bio, Inc. — Insider Trades
$2.89 USD
$0.05 (1.76%)
- Volume
- 940.36K
- Average Volume
- 1.21M
- Market Capitalization
- $64.95M
- P/E Ratio
- -1.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.92
- Year Low
- $0.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.48
Insider Activity Summary (Last 12 Months)
Insiders Buying
39
Insiders Selling
4
Amount of Insider Selling
$64000
BOLD Insider Buying/Selling by Quarter
BOLD Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| TANG KEVIN | 10 percent owner | 2026-07-21 | P-Purchase | 2.44 | 2026-07-21 |
| TANG KEVIN | 10 percent owner | 2026-07-20 | P-Purchase | 2.44 | 2026-07-21 |
| TANG KEVIN | 10 percent owner | 2026-07-17 | P-Purchase | 2.44 | 2026-07-21 |
| TANG KEVIN | 10 percent owner | 2026-07-16 | P-Purchase | 2.44 | 2026-07-16 |
| TANG KEVIN | 10 percent owner | 2026-07-15 | P-Purchase | 2.44 | 2026-07-16 |
| TANG KEVIN | 10 percent owner | 2026-07-14 | P-Purchase | 2.43 | 2026-07-16 |
| TANG KEVIN | 10 percent owner | 2026-07-13 | P-Purchase | 2.42 | 2026-07-13 |
| TANG KEVIN | 10 percent owner | 2026-07-10 | P-Purchase | 2.43 | 2026-07-13 |
| TANG KEVIN | 10 percent owner | 2026-07-09 | P-Purchase | 2.48 | 2026-07-13 |
| TANG KEVIN | 10 percent owner | 2026-07-08 | P-Purchase | 2.46 | 2026-07-08 |
| TANG KEVIN | 10 percent owner | 2026-07-07 | P-Purchase | 2.48 | 2026-07-08 |
| TANG KEVIN | 10 percent owner | 2026-07-06 | P-Purchase | 2.49 | 2026-07-08 |
| CRANDELL KEITH | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| CRANDELL KEITH | 10 percent owner | 2026-07-01 | S-Sale | 2.49 | 2026-07-06 |
| CRANDELL KEITH | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | 2026-07-01 | S-Sale | 2.49 | 2026-07-06 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| TANG KEVIN | 10 percent owner | 2026-07-02 | P-Purchase | 2.49 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-07-01 | P-Purchase | 2.49 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-06-30 | P-Purchase | 2.5 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-06-30 | P-Purchase | 2.54 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-06-29 | P-Purchase | 2.48 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-29 | P-Purchase | 2.47 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-26 | P-Purchase | 2.54 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-26 | P-Purchase | 2.55 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-25 | P-Purchase | 2.56 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-25 | P-Purchase | 2.48 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-25 | 0 | 2026-06-29 | |
| Whiting Nancy | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Lim Jonathan E | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Christensen James | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Lew Jennifer | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Oien Jessica | officer: See Remarks | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Hassig Christian | officer: Chief Scientific Officer | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Doebele Robert | officer: Chief Medical Officer | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Hornby Zachary | director, officer: President & CEO | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| HINKLE DAVID A | officer: See Remarks | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Brennan Christine | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Christensen James | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Lew Jennifer | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Lim Jonathan E | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Burow Kristina | director, 10 percent owner: | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Whiting Nancy | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Doebele Robert | officer: Chief Medical Officer | 2025-02-03 | A-Award | 2.23 | 2025-02-03 |
| Doebele Robert | 2025-02-03 | 0 | 2025-02-03 | ||
| HINKLE DAVID A | officer: See Remarks | 2025-01-22 | A-Award | 2.57 | 2025-01-23 |
| Hassig Christian | officer: Chief Scientific Officer | 2025-01-22 | A-Award | 2.57 | 2025-01-23 |
| Hornby Zachary | director, officer: President & CEO | 2025-01-22 | A-Award | 2.57 | 2025-01-23 |
| Oien Jessica | officer: See Remarks | 2025-01-22 | A-Award | 2.57 | 2025-01-23 |
| HINKLE DAVID A | officer: See Remarks | 2024-10-11 | 0 | 2024-10-15 | |
| HINKLE DAVID A | officer: See Remarks | 2024-10-11 | 0 | 2024-10-15 | |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | D-Return | 3.71 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | D-Return | 4.1 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | D-Return | 8.19 | 2024-08-20 |
| Hassig Christian | officer: Chief Scientific Officer | 2024-08-19 | D-Return | 16 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | D-Return | 16 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | D-Return | 8.19 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | D-Return | 4.49 | 2024-08-20 |
| Oien Jessica | officer: See Remarks | 2024-08-19 | D-Return | 4.1 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | D-Return | 4.1 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | D-Return | 16 | 2024-08-20 |
| Hornby Zachary | director, officer: President & CEO | 2024-08-19 | D-Return | 8.19 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | D-Return | 16 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | D-Return | 8.19 | 2024-08-20 |
| Abdollahian Neil | officer: Chief Business Officer | 2024-08-19 | D-Return | 4.1 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | D-Return | 16 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | D-Return | 8.19 | 2024-08-20 |
| Wagner Klaus W. | officer: Chief Medical Officer | 2024-08-19 | D-Return | 4.1 | 2024-08-20 |
| Rubin Jami | officer: Chief Financial Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Rubin Jami | officer: Chief Financial Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Rubin Jami | officer: Chief Financial Officer | 2024-08-19 | A-Award | 3.56 | 2024-08-20 |
| Rubin Jami | officer: Chief Financial Officer | 2024-08-19 | D-Return | 16 | 2024-08-20 |
| Rubin Jami | officer: Chief Financial Officer | 2024-08-19 | D-Return | 8.19 | 2024-08-20 |